My Companies
Notification
Account
Log Out
Login
API subsidiary RPG Active Pharma to get Rs. 243.33 Cr PE infusion for 40% stake (commitment up to Rs. 700 Cr) and acquire Actis Generics for Rs. 80 Cr — first M&A after years; API slump sale to WOS for Rs. 33.55 Cr agreed.
RPG Life Sciences Carves Out API Business, Raises ₹243 Crore From InvAscent
RPG Life Sciences Approves ₹243 Crore API Subsidiary Investment And Acquisition
RPG Life Sciences Board Approves ₹243 Crore Investment And Actis Generics Acquisition